These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19736707)
1. Familial hypercholesterolaemia: different perspectives. Jones JL; Lakasing E; Archontakis S Nurs Stand; 2009 Aug 19-25; 23(50):35-8. PubMed ID: 19736707 [TBL] [Abstract][Full Text] [Related]
2. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
3. Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor. El Aziz S; Chadli A; El Ghomari H; Farouqi A BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669020 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R). Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous familial hypercholesterolemia case study. Friedrich DA J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615 [No Abstract] [Full Text] [Related]
7. Current status of familial hypercholesterolemia in Chinese populations. Tomlinson B; Hu M; Chow E Curr Opin Lipidol; 2019 Apr; 30(2):94-100. PubMed ID: 30649024 [TBL] [Abstract][Full Text] [Related]
8. [Drug of the month. Ezetimibe/simvastatin tablet (Inegy)]. Scheen AJ; Radermecker RP Rev Med Liege; 2007 Sep; 62(9):585-90. PubMed ID: 17966796 [TBL] [Abstract][Full Text] [Related]
9. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824 [TBL] [Abstract][Full Text] [Related]
10. Is there a problem with ezetimibe or just ENHANCEd hype? Whayne TF Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445 [No Abstract] [Full Text] [Related]
11. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia. Heath KE; Gudnason V; Humphries SE; Seed M Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial. Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602 [TBL] [Abstract][Full Text] [Related]
13. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
15. After ENHANCE: is more LDL cholesterol lowering even better? Stein EA Clin Chem; 2008 Jun; 54(6):940-2. PubMed ID: 18403568 [No Abstract] [Full Text] [Related]
16. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene. Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007 [TBL] [Abstract][Full Text] [Related]